2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
Kellokumpu-Lehtinen, Pirkko-Liisa, Prof, Harmenberg, Ulrika, MD, Joensuu, Timo, MD, McDermott, Ray, MD, Hervonen, Petteri, MD, Ginman, Claes, MD, Luukkaa, Marjaana, MD, Nyandoto, Paul, MD, Hemminki, Akseli, Prof, Nilsson, Sten, Prof, McCaffrey, John, Prof, Asola, Raija, MD, Turpeenniemi-Hujanen, Taina, Prof, Laestadius, Fredrik, MD, Tasmuth, Tiina, MD, Sandberg, Katinka, MD, Keane, Maccon, MD, Lehtinen, Ilari, BSc, Luukkaala, Tiina, MSc, Joensuu, Heikki, Prof
Published in The lancet oncology (01.02.2013)
Published in The lancet oncology (01.02.2013)
Get full text
Journal Article
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
Petrylak, Daniel P, de Wit, Ronald, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Matsubara, Nobuaki, Alekseev, Boris, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Hegemann, Miriam, Percent, Ivor J, Lee, Jae-Lyun, Tucci, Marcello, Tortora, Giampaolo, Safina, Sufia, Rodriguez-Vida, Alejo, Harputluoglu, Hakan, Widau, Ryan C, Liepa, Astra M, Hamid, Oday, Zimmermann, Annamaria H, Bell-McGuinn, Katherine M, Wong, Suet-Lai Shirley, Hovey, Elizabeth Jane, Ng, Siobhan Su Wan, Dumez, Herlinde, Cheng, Susanna Yee-Shan, Jensen, Niels Viggo, Laguerre, Brigitte, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Grimm, Marc-Oliver, Gakis, Georgios, Schultze-Seemann, Wolfgang, Mavroudis, Dimitrios, Révész, Janos, Geczi, Lajos, Rosenbaum, Eli, Kejzman, Daniel, Peer, Avivit, Sarid, David, Tortora, Giampaolo, Bracarda, Sergio, Necchi, Andrea, Massari, Francesco, Osawa, Takahiro, Shinohara, Nobuo, Fukuta, Fumimasa, Obara, Wataru, Tomita, Yoshihiko, Kawai, Koji, Matsubara, Nobuaki, Oyama, Masafumi, Nagata, Masayoshi, Uemura, Motohide, Nishimura, Kazuo, Kawakita, Mutsushi, Inokuchi, Junichi, Yokomizo, Akira, Lee, Jae-Lyun, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Flores, Claudia Lorena Urzua, Blaisse, Reinoud J B, van der Heijden, Michiel S, de Wit, Ronald, Aarts, Maureen J B, Wojcik-Tomaszewska, Joanna, Tomczak, Piotr, Sikora-Kupis, Bozena, Safina, Sufia Z, Alekseev, Boris, Semenov, Andrey, Fomkin, Roman, Del Muro, F Xavier García, Lin, Chien-Liang, Yeh, Su-Peng, Çiçin, Irfan, Harputluoglu, Hakan, Erman, Mustafa, Golovko, Yurii, Bondarenko, Igor, Powles, Thomas, Syndikus, Isabel, Huddart, Robert, Sundar, Santhanam, Chowdhury, Simon, Drakaki, Alexandra, Petrylak, Daniel, Schwarz, James, Percent, Ivor, Hainsworth, John, Herms, Benjamin, Tagawa, Scott, Vaishampayan, Ulka
Published in The Lancet (British edition) (18.11.2017)
Published in The Lancet (British edition) (18.11.2017)
Get full text
Journal Article
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Petrylak, Daniel P, de Wit, Ronald, Chi, Kim N, Drakaki, Alexandra, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Hussain, Syed A, Fléchon, Aude, van der Heijden, Michiel S, Matsubara, Nobuaki, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Percent, Ivor J, Lee, Jae-Lyun, Laestadius, Fredrik, Peer, Avivit, Garcia del Muro, Xavier, Cicin, Irfan, Vaishampayan, Ulka, Aragon-Ching, Jeanny B, Hamid, Oday, Wijayawardana, Sameera, Russo, Francesca, Zimmermann, Annamaria H, Bell-McGuinn, Katherine M, Wong, Suet-Lai Shirley, Tan, Thean Hsiang, Hovey, Elizabeth Jane, Clay, Timothy Dudley, Wan Ng, Siobhan Su, Rutten, Annemie, Dumez, Herlinde, Ferrario, Cristiano, Sengeloev, Lisa, Jensen, Niels Viggo, Thibault, Constance, Laguerre, Brigitte, Joly, Florence, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Stöckle, Michael, Grimm, Marc-Oliver, Schultze-Seemann, Wolfgang, Kalofonos, Haralambos, Mavroudis, Dimitrios, Karavasilis, Vasilis, Révész, Janos, Leibowitz-Amit, Raya, Kejzman, Daniel, Sarid, David, Massari, Francesco, Osawa, Takahiro, Miyajima, Naoto, Shinohara, Nobuo, Fukuta, Fumimasa, Ohyama, Chikara, Obara, Wataru, Yamashita, Shinichi, Tomita, Yoshihiko, Kawai, Koji, Oyama, Masafumi, Yonese, Junji, Uemura, Motohide, Tsunemori, Hiroyuki, Yokomizo, Akira, Nagamori, Satoshi, Lee, Hyo Jin, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Lee, Yun-Gyoo, Vazquez Cortés, Leticia, Lorena Urzua Flores, Claudia, Blaisse, Reinoud J.B., Aarts, Maureen J.B., Schenker, Michael, Herzal, Alina Amalia, Udrea, Anghel Adrian, Karlov, Petr, Fomkin, Roman, Grande, Enrique, Lin, Chia-Chi, Yeh, Su-Peng, Erman, Mustafa, Urun, Yuksel, Golovko, Yuriy, Sinielnikov, Ivan, Crabb, Simon J., Syndikus, Isabel, Sundar, Santhanam, Pan, Chong Xian, Schwarz, James K., Acs, Peter Istvan, Hainsworth, John D., Lawler, William Eyre
Published in The lancet oncology (01.01.2020)
Published in The lancet oncology (01.01.2020)
Get full text
Journal Article
Pre-therapeutic dihydropyridimidine dehydrogenase (DPD) deficiency screening: Impact on fluoropyrimidine dose reduction at the second chemotherapy cycle and on early severe toxicity
De Metz, Côme, Hennart, Benjamin, Le Deley, Marie-Cecile, Cren, Pierre-Yves, Desauw, Christophe, Bourgeois, Vincent, Laestadius, Fredrik, Rad, Emilia, Lebellec, Loic, Penel, Nicolas, Carnot, Aurelien
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer
DROR MICHAELSON, M, OUDARD, Stephane, LAESTADIUS, Fredrik, ULLEN, Anders, BAHL, Amit, CASTELLANO, Daniel, GSCHWEND, Juergen, MAURINA, Tristan, CHOW MANEVAL, Edna, WANG, Shaw-Ling, LECHUGA, Maria Jose, PAOLINI, Jolanda, OU, Yen-Chuan, ISAN CHEN, SENGELØV, Lisa, SAAD, Fred, HOUEDE, Nadine, OSTLER, Peter, STENZL, Arnulf, DAUGAARD, Gedske, JONES, Robert
Published in Journal of clinical oncology (10.01.2014)
Published in Journal of clinical oncology (10.01.2014)
Get full text
Journal Article
Conference Proceeding
Predictors for malignant tissue (MT) in residual masses (RM) of non-seminomatous germ cell tumors (NSGCT) treated by chemotherapy (CT) before surgery
Stern, Natacha, Bompas, Emmanuelle, Bogart, Emilie, Laestadius, Fredrik, Mouillet, Guillaume, Schlurmann, Friederike, Leblanc, Eric, Penel, Nicolas, Lotz, Jean-Pierre, Amela, Eric
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Ziv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial
Adenis, Antoine, Ghiringhelli, Francois, Raoul, Jean Luc, Tresch, Emmanuelle, Thirot-Bidault, Anne, Vincent, Julie, El Hajbi, Farid, Hebbar, Mohamed, Bouchahda, Mohamed, Jarraya, Hajer, Feutray, Sylvaine, Amela, Eric, Laestadius, Fredrik, Le Deley, Marie-Cécile, Taieb, Sophie, Soncin, Fabrice, Dochy, Emmanuelle, Delaine, Stephanie Clisant, Penel, Nicolas, Lassau, Nathalie
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Triweekly docetaxel versus biweekly docetaxel as a treatment for advanced castration resistant prostate cancer: Quality of life analysis
Kellokumpu-Lehtinen, Pirkko-Liisa Irmeli, Harmenberg, Ulrika, Hervonen, Petteri, Joensuu, Timo K., McDermott, Raymond S., Ginman, Claes, Luukkaa, Marjaana, Nyandoto, Paul, Hemminki, Akseli, Nilsson, Sten, McCaffrey, John, Asola, Raija, Turpeenniemi Hujanen, Taina, Laestadius, Fredrik, Tasmuth, Tiina, Sandberg, Katinka, Keane, Maccon M., Lehtinen, Ilari, Luukkaala, Tiina, Joensuu, Heikki
Published in JOURNAL OF CLINICAL ONCOLOGY (01.02.2014)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.02.2014)
Get full text
Journal Article
Conference Proceeding